ARCHIVES

Funding and Direction of IL-2/LAK Trials Questioned By DCT Board

This article is from The Cancer Letter archive.

Vol. 15 No. 09 | March 3, 1989

Download PDF Visit The Full Archive

Related Articles

NCI Chief Operating Officer Lawrence Ray To Retire

April 24, 2009

Wyngaarden Opens Up Search for NCI Director, Invites Recommendations From Cancer Groups

September 30, 1988

Cancer Programs Close Amid Gridlock

October 4, 2013

NIH Director Calls For Lifting Federal Ban on Embryonic Stem Cell Research.

March 23, 2007

ODAC Okays Photofrin for Obstructive Esophageal Cancer

September 23, 1994

Cooperative group chairman suggest changes to incentive system.

August 13, 2004